Antonio R. Pera - Aug 14, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
Director
Signature
/s/ Antonio R. Pera, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 14, 2023
Transactions value $
-$181,110
Form type
4
Date filed
8/15/2023, 08:45 PM
Previous filing
May 24, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$181K -3K -8.19% $60.37 33.6K Aug 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive.